Mer­ck en­lists Ther­mo Fish­er to make Covid-19 an­tivi­ral mol­nupi­ravir for Cana­da, UK

Just af­ter Mer­ck an­nounced a deal to part­ner with a man­u­fac­tur­er to make its ex­per­i­men­tal Covid-19 pill mol­nupi­ravir in the US, the drug­mak­er has reached a sim­i­lar part­ner­ship to make the pill for dis­tri­b­u­tion through­out the rest of the world as well.

Mer­ck will part­ner with Ther­mo Fish­er Sci­en­tif­ic to man­u­fac­ture the pill for Cana­da, the UK, sev­er­al mar­kets in the EU and Asia, as well as Latin Amer­i­ca. The Whit­by, On­tario site will be one of three in the world mak­ing the pill, which was de­vel­oped with Ridge­back Bio­ther­a­peu­tics.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER